- Home
- DYN vs STEW Comparison
DYN vs STEW Comparison
Compare DYN & STEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- STEW
- Stock Information
- Founded
- DYN 1984
- STEW 1972
- Country
- DYN United States
- STEW United States
- Employees
- DYN N/A
- STEW N/A
- Industry
- DYN Medicinal Chemicals and Botanical Products
- STEW Investment Managers
- Sector
- DYN Health Care
- STEW Finance
- Exchange
- DYN Nasdaq
- STEW Nasdaq
- Market Cap
- DYN 1.9B
- STEW 1.7B
- IPO Year
- DYN 2020
- STEW N/A
- Fundamental
- Price
- DYN $21.11
- STEW $17.81
- Analyst Decision
- DYN Strong Buy
- STEW
- Analyst Count
- DYN 15
- STEW 0
- Target Price
- DYN $36.53
- STEW N/A
- AVG Volume (30 Days)
- DYN 3.2M
- STEW 84.5K
- Earning Date
- DYN 11-05-2025
- STEW 01-01-0001
- Dividend Yield
- DYN N/A
- STEW 3.71%
- EPS Growth
- DYN N/A
- STEW N/A
- EPS
- DYN N/A
- STEW 1.44
- Revenue
- DYN N/A
- STEW N/A
- Revenue This Year
- DYN N/A
- STEW N/A
- Revenue Next Year
- DYN N/A
- STEW N/A
- P/E Ratio
- DYN N/A
- STEW $10.34
- Revenue Growth
- DYN N/A
- STEW N/A
- 52 Week Low
- DYN $6.36
- STEW $11.97
- 52 Week High
- DYN $31.32
- STEW $14.94
- Technical
- Relative Strength Index (RSI)
- DYN 58.23
- STEW 48.90
- Support Level
- DYN $18.20
- STEW $17.60
- Resistance Level
- DYN $21.98
- STEW $17.94
- Average True Range (ATR)
- DYN 1.78
- STEW 0.21
- MACD
- DYN -0.17
- STEW 0.01
- Stochastic Oscillator
- DYN 57.30
- STEW 53.19
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About STEW SRH Total Return Fund Inc.
SRH Total Return Fund, Inc. is a non-diversified closed-end management investment company. The company's investment objective is to seek total returns. Its fund utilizes a bottom-up, value-driven investment process to identify securities of good quality businesses trading below estimated intrinsic value. The Funds are available as an actively-managed closed-end fund, an actively managed ETF and a passively-managed ETF.